HER2-Positive Breast Cancer Survival Rates: Statistics & More - herceptin sensitive breast cancer


HER2-positive breast cancer: What is it? - Mayo Clinic herceptin sensitive breast cancer

Herceptin works by attaching itself to the HER2 receptors on the surface of breast cancer cells and blocking them from receiving growth signals. By blocking the signals, Herceptin can slow or stop the growth of the breast cancer. Herceptin is an example of an immune targeted therapy.

Herceptin® (trastuzumab) is an approved adjuvant therapy for HER2+ early-stage breast cancer, a treatment given after the main breast cancer treatment (usually surgery). See full safety & Boxed Warnings for more information.

Breast cancers are ER-positive, HER2-positive, or triple negative. The type of breast cancer you have determines the type of medication you take. Learn more from experts at WebMD.Author: Gina Shaw.

Sep 18, 2019 · HER2 is a protein that causes breast cancer cells to grow, and it can cause aggressive breast cancer. Read about survival rates, treatments, and more.Author: Robin Madell.